To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
Read time: 1 mins
Last updated:30th Apr 2013
To evaluate the efficacy and safety of 0.5 mg in adult patients with visual impairment due to macular edema (ME).
|Study start date||2013-04-30|